SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 151 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q4 2017. The put-call ratio across all filers is 1.99 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $99,000 | +39.4% | 58,464 | +42.4% | 0.00% | 0.0% |
Q2 2018 | $71,000 | -82.4% | 41,051 | -77.3% | 0.00% | -85.7% |
Q4 2017 | $404,000 | -46.0% | 181,127 | +47.5% | 0.01% | -77.4% |
Q4 2016 | $748,000 | +599.1% | 122,788 | +532.9% | 0.03% | +342.9% |
Q3 2016 | $107,000 | -71.6% | 19,400 | -70.8% | 0.01% | -82.9% |
Q4 2015 | $377,000 | – | 66,500 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nantahala Capital Management | 11,578,568 | $20,147,000 | 0.82% |
Virtus ETF Advisers LLC | 441,461 | $768,000 | 0.68% |
Hikari Power Ltd | 2,300,000 | $4,002,000 | 0.44% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,403,149 | $2,441,000 | 0.17% |
KNOTT DAVID M | 225,400 | $392,000 | 0.15% |
Clear Harbor Asset Management, LLC | 277,110 | $482,000 | 0.09% |
Malaga Cove Capital, LLC | 97,264 | $169,000 | 0.09% |
Lehman Financial Resources, Inc. | 80,800 | $140,000 | 0.07% |
Cheyne Capital Management (UK) LLP | 50,000 | $87,000 | 0.06% |
Ballew Advisors, Inc | 26,200 | $46,000 | 0.05% |